查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1825708

2025年DNA诊断全球市场报告

DNA Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年DNA诊断市场将强劲成长，2029年将达到373.5亿美元，复合年增长率为9.9%。预测期内的成长动力包括：癌症发生率的上升、标准化诊断测试需求的增加、遗传性疾病盛行率的上升、对生物标记发现、罕见疾病及其治疗的日益关注，以及远端医疗和远距检测的成长。预测期内的主要趋势包括：微生物组分析的整合、区块链技术的整合、多组体学资料的整合、非侵入性检测、多体学整合、可携式和照护现场DNA诊断设备的开发以及次世代定序仪(NGS)。

未来五年9.9%的成长预测，较我们先前对该市场的预测略有下降0.9%。这一下降主要源自于美国与其他国家之间关税的影响。贸易摩擦可能导致韩国和瑞士开发的基于聚合酵素链锁反应(PCR)的诊断试剂盒和基因筛检套件价格上涨，导致检测结果出炉速度变慢，病理科室成本上升，从而扰乱美国的临床检测。互惠关税以及不断升级的贸易摩擦和贸易限制对全球经济和贸易的负面影响，可能产生更广泛的影响。

遗传疾病的日益普及有望在短期内推动DNA诊断市场的扩张。遗传疾病是指基因组异常所导致的健康问题，其发生率呈上升趋势，这归因于多种因素，包括诊断能力的提高、基因检测的普及、环境影响以及人群中的亲属关係。这些因素共同促进了人们对遗传疾病的认识和辨识。 DNA诊断在透过分析遗传物质来准确识别遗传疾病、促进早期诊断、制定个人化治疗方案以及製定明智的计划生育决策方面发挥关键作用。例如，根据世界卫生组织（WHO）2023年2月的数据，先天性疾病每年导致全球约24万新生儿死亡，另有17万名1个月至5岁儿童死亡。因此，遗传疾病日益流行的趋势是DNA诊断市场成长的驱动力。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球 DNA 诊断：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球DNA诊断市场：成长率分析
  • 全球 DNA 诊断市场表现：规模与成长，2019-2024 年
  • 全球 DNA 诊断市场预测：规模与成长，2024-2029 年，2034 年
  • 全球 DNA 诊断：总潜在市场 (TAM)

第六章 市场细分

  • 全球 DNA 诊断市场（按产品类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 试剂
  • 软体
  • 服务
  • 全球 DNA 诊断市场（按技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素链锁反应
  • 微阵列
  • 原位杂合反应
  • 定序技术
  • 质谱法
  • 全球DNA诊断市场的应用、表现及预测（2019-2024年、2024-2029年、2034年）
  • 肿瘤学
  • 感染疾病治疗
  • 肌源性疾病的治疗
  • 临床诊断确认
  • 产前
  • 胚胎着床前
  • 其他的
  • 全球 DNA 诊断市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 照护现场
  • 诊断中心
  • 自我检测或非处方药
  • 全球 DNA 诊断市场：设备细分、类型、性能和预测（2019-2024 年、2024-2029 年、2034 年）
  • DNA分析仪
  • PCR仪（聚合酵素链锁反应）
  • 定序仪（新一代定序、桑格定序）
  • 电泳系统
  • 基因表现分析装置
  • 微阵列系统
  • 流式细胞仪
  • 光强度
  • 全球 DNA 诊断市场：试剂细分、类型、效能及预测（2019-2024 年、2024-2029 年、2034 年）
  • PCR试剂
  • DNA萃取试剂套件
  • 定序试剂
  • DNA检测抗体
  • 萤光染料和探针
  • 核酸纯化化学品
  • DNA分析缓衝液
  • 杂合反应和扩增试剂套件
  • 全球 DNA 诊断市场：软体细分、类型、效能和预测（2019-2024 年、2024-2029 年、2034 年）
  • DNA数据分析软体
  • 生物资讯平台
  • 用于定序资料的基因组学软体
  • 实验室资讯管理系统（LIMS）
  • 数据视觉化工具
  • 基因突变分析软体
  • 基因组图谱软体
  • 全球 DNA 诊断市场：服务细分、类型、绩效及预测（2019-2024 年、2024-2029 年、2034 年）
  • 基因检测服务
  • DNA定序服务
  • 生物资讯咨询与分析
  • 临床诊断服务
  • 遗传咨询服务
  • 客製化DNA诊断服务
  • 研发服务

第七章 区域和国家分析

  • 全球 DNA 诊断市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球 DNA 诊断市场：按国家、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • DNA诊断市场：竞争格局
  • DNA诊断市场：公司简介
    • F. Hoffmann-La Roche Ltd
    • Bayer AG
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation

第31章：其他领先和创新企业

  • Becton, Dickinson and Company
  • Laboratory Corporation
  • Quest Diagnostics Incorporated
  • Eurofins Scientific SE
  • Agilent Technologies
  • Illumina Inc
  • PerkinElmer Inc
  • bioMerieux SA
  • Beckman Coulter Inc
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc
  • QIAGEN NV
  • Natera Inc
  • Myriad Genetics Inc.
  • BGI Genomics Co. Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029 年 DNA 诊断市场：提供新机会的国家
  • 2029 年 DNA 诊断市场：细分领域带来新机会
  • 2029 年 DNA 诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r30021u

DNA diagnostics involves utilizing genetic testing techniques to examine DNA, RNA, and proteins for medical, forensic, or research purposes. These tests offer valuable insights into genetic predispositions, disease susceptibility, and ancestry, thereby revolutionizing the fields of medicine and genetics and providing effective tools for health management.

DNA diagnostic products encompass instruments, reagents, software, and services. Instruments are specialized equipment used for DNA sample analysis, employing technologies such as polymerase chain reaction, microarray, in-situ hybridization, sequencing, and mass spectrometry. These technologies find applications in diverse areas including oncology, infectious disease treatment, myogenic disorder treatment, clinical diagnostics, prenatal and pre-implantation testing. End users of DNA diagnostic products include point-of-care facilities, diagnostic centers, and individuals seeking self-testing or over-the-counter solutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The DNA diagnostics market research report is one of a series of new reports from The Business Research Company that provides DNA diagnostics market statistics, including DNA diagnostics industry global market size, regional shares, competitors with a DNA diagnostics market share, detailed DNA diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the DNA diagnostics industry. This DNA diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dna diagnostics market size has grown rapidly in recent years. It will grow from $23.1 billion in 2024 to $25.62 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to rising demand for personalized medicine, increasing adoption of genetic testing and molecular diagnostics in clinical practice, rising biomedical research, the increasing number of cancer patients, and the growing use of diagnostics tests.

The dna diagnostics market size is expected to see strong growth in the next few years. It will grow to $37.35 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing the prevalence of cancers, increasing demand for standardized diagnostic tests, rising prevalence of genetic disorders, increasing focus on biomarker discovery, rare diseases and orphan drugs, and growth of telemedicine and remote testing. Major trends in the forecast period include the integration of microbiome analysis, integration of blockchain technology, the integration of multiple omics data, non-invasive testing, multi-omics integration, the development of portable and point-of-care DNA diagnostic devices, and next-generation sequencing (NGS).

The forecast of 9.9% growth over the next five years reflects a modest reduction of 0.9% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. clinical testing by inflating prices of polymerase chain reaction(PCR)-based diagnostic panels and genetic screening kits developed in South Korea and Switzerland, resulting in slower test results and higher pathology department costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of genetic disorders is poised to drive the expansion of the DNA diagnostics market in the foreseeable future. Genetic disorders, characterized by health issues stemming from abnormalities in the genome, are on the rise due to several factors including enhanced diagnostic capabilities, broader genetic testing availability, environmental influences, and consanguinity within populations. These factors collectively contribute to a heightened awareness and identification of genetic disorders. DNA diagnostics plays a crucial role in precisely identifying genetic disorders through the analysis of genetic material, facilitating early diagnosis, tailored treatment approaches, and informed family planning decisions. For example, according to the World Health Organization (WHO) in February 2023, congenital diseases are responsible for approximately 240,000 neonatal deaths worldwide annually, with an additional 170,000 deaths occurring in children aged between 1 month and 5 years. Consequently, the escalating prevalence of genetic disorders serves as a key driver for the growth of the DNA diagnostics market.

Leading players in the DNA diagnostics sector are directing their efforts towards the development of innovative products, including liquid biopsy tests, designed to detect various types of cancer in their early stages. Liquid biopsy tests represent a minimally invasive diagnostic approach that identifies and analyzes biomarkers, such as circulating tumor cells (CTCs), cell-free DNA (cfDNA), or exosomes, present in the bloodstream and originating from tumors or other cells. For instance, in May 2023, Laboratory Corporation, a prominent US-based healthcare diagnostics company, introduced a novel liquid biopsy test named LabCorp Plasma Focus. This test is designed to identify targeted therapies for patients diagnosed with advanced or metastatic solid tumors. Leveraging genetic sequencing technology, LabCorp Plasma Focus evaluates circulating cell-free DNA (cfDNA) released by tumor cells, enabling oncologists to personalize treatment strategies and enhance patient care through targeted therapy plans.

In November 2022, Myriad Genetics Inc., a leading US-based company specializing in genetic testing and personalized medicine, acquired Gateway Genomics for approximately $67.5 million. This acquisition broadens Myriad's portfolio in women's health and oncology testing, offering patients more comprehensive and personalized genetic testing solutions. Gateway Genomics LLC, the acquired company, specializes in developing prenatal and pediatric genomic tests, aligning with Myriad's commitment to expanding its presence and capabilities in key segments of genetic diagnostics.

Major companies operating in the DNA diagnostics market are F. Hoffmann-La Roche Ltd, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc, PerkinElmer Inc, bioMerieux SA, Beckman Coulter Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN N.V., Natera Inc, Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc, 23andMe Holding Co, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Veritas Genetics

North America was the largest region in the DNA diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the DNA diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The DNA diagnostics market consists of revenues earned by entities by providing services such as ancestry testing, paternity or maternity testing, genetic health risk assessment, carrier testing, pharmacogenetic testing, forensic DNA analysis, and genetic counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The DNA diagnostics market also includes sales of DNA extraction kits, thermal cyclers or polymerase chain reaction machines, DNA sequencers, gel electrophoresis systems, DNA microarrays, automated liquid handling systems, and DNA storage and preservation kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

DNA Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dna diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dna diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dna diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Instruments; Reagents; Software And Services
  • 2) By Technology: Polymerase Chain Reaction; Microarray; In-situ Hybridization; Sequencing Technology; Mass Spectrometry
  • 3) By Application: Oncology; Infectious Diseases Treatment; Myogenic Disorder Treatment; Clinical Diagnostic Confirmation; Prenatal; Pre-Implantation; Other Applications
  • 4) By End User: Point Of Care; Diagnostic Centers; Self-Testing Or Over-The-Counter (OTC)
  • Subsegments:
  • 1) By Instruments: DNA Analyzers; PCR Machines (Polymerase Chain Reaction); Sequencers (Next-Generation Sequencing, Sanger Sequencing); Electrophoresis Systems; Gene Expression Analyzers; Microarray Systems; Flow Cytometers; Spectrophotometers
  • 2) By Reagents: PCR Reagents; DNA Extraction Kits; Sequencing Reagents; Antibodies For DNADetection; Fluorescent Dyes And Probes; Chemicals For Nucleic Acid Purification; Buffer Solutions For DNA Analysis; Hybridization And Amplification Kits
  • 3) By Software: DNA Data Analysis Software; Bioinformatics Platforms; Genomics Software For Sequencing Data; Laboratory Information Management Systems (LIMS); Data Visualization Tools; Genetic Variant Analysis Software; Genome Mapping Software
  • 4) By Services: Genetic Testing Services; DNA Sequencing Services; Bioinformatics Consulting And Analysis; Clinical Diagnostic Services; Genetic Counseling Services; Custom DNA Diagnostics Services; Research And Development Services
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Bayer AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton, Dickinson and Company; Laboratory Corporation; Quest Diagnostics Incorporated; Eurofins Scientific SE; Agilent Technologies; Illumina Inc; PerkinElmer Inc; bioMerieux SA; Beckman Coulter Inc; Sysmex Corporation; Bio-Rad Laboratories Inc; QIAGEN N.V.; Natera Inc; Myriad Genetics Inc.; BGI Genomics Co. Ltd.; Cepheid; NeoGenomics Laboratories Inc; 23andMe Holding Co; Ambry Genetics Corporation; Biocartis SA; CENTOGENE N.V.; Veritas Genetics
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. DNA Diagnostics Market Characteristics

3. DNA Diagnostics Market Trends And Strategies

4. DNA Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global DNA Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global DNA Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global DNA Diagnostics Market Growth Rate Analysis
  • 5.4. Global DNA Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global DNA Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global DNA Diagnostics Total Addressable Market (TAM)

6. DNA Diagnostics Market Segmentation

  • 6.1. Global DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagents
  • Software And Services
  • 6.2. Global DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction
  • Microarray
  • In-situ Hybridization
  • Sequencing Technology
  • Mass Spectrometry
  • 6.3. Global DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Infectious Diseases Treatment
  • Myogenic Disorder Treatment
  • Clinical Diagnostic Confirmation
  • Prenatal
  • Pre-Implantation
  • Other Applications
  • 6.4. Global DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Point Of Care
  • Diagnostic Centers
  • Self-Testing Or Over-The-Counter (OTC)
  • 6.5. Global DNA Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • DNA Analyzers
  • PCR Machines (Polymerase Chain Reaction)
  • Sequencers (Next-Generation Sequencing, Sanger Sequencing)
  • Electrophoresis Systems
  • Gene Expression Analyzers
  • Microarray Systems
  • Flow Cytometers
  • Spectrophotometers
  • 6.6. Global DNA Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR Reagents
  • DNA Extraction Kits
  • Sequencing Reagents
  • Antibodies For DNA Detection
  • Fluorescent Dyes And Probes
  • Chemicals For Nucleic Acid Purification
  • Buffer Solutions For DNA Analysis
  • Hybridization And Amplification Kits
  • 6.7. Global DNA Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • DNA Data Analysis Software
  • Bioinformatics Platforms
  • Genomics Software For Sequencing Data
  • Laboratory Information Management Systems (LIMS)
  • Data Visualization Tools
  • Genetic Variant Analysis Software
  • Genome Mapping Software
  • 6.8. Global DNA Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genetic Testing Services
  • DNA Sequencing Services
  • Bioinformatics Consulting And Analysis
  • Clinical Diagnostic Services
  • Genetic Counseling Services
  • Custom DNA Diagnostics Services
  • Research And Development Services

7. DNA Diagnostics Market Regional And Country Analysis

  • 7.1. Global DNA Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global DNA Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific DNA Diagnostics Market

  • 8.1. Asia-Pacific DNA Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China DNA Diagnostics Market

  • 9.1. China DNA Diagnostics Market Overview
  • 9.2. China DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India DNA Diagnostics Market

  • 10.1. India DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan DNA Diagnostics Market

  • 11.1. Japan DNA Diagnostics Market Overview
  • 11.2. Japan DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia DNA Diagnostics Market

  • 12.1. Australia DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia DNA Diagnostics Market

  • 13.1. Indonesia DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea DNA Diagnostics Market

  • 14.1. South Korea DNA Diagnostics Market Overview
  • 14.2. South Korea DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe DNA Diagnostics Market

  • 15.1. Western Europe DNA Diagnostics Market Overview
  • 15.2. Western Europe DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK DNA Diagnostics Market

  • 16.1. UK DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany DNA Diagnostics Market

  • 17.1. Germany DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France DNA Diagnostics Market

  • 18.1. France DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy DNA Diagnostics Market

  • 19.1. Italy DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain DNA Diagnostics Market

  • 20.1. Spain DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe DNA Diagnostics Market

  • 21.1. Eastern Europe DNA Diagnostics Market Overview
  • 21.2. Eastern Europe DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia DNA Diagnostics Market

  • 22.1. Russia DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America DNA Diagnostics Market

  • 23.1. North America DNA Diagnostics Market Overview
  • 23.2. North America DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA DNA Diagnostics Market

  • 24.1. USA DNA Diagnostics Market Overview
  • 24.2. USA DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada DNA Diagnostics Market

  • 25.1. Canada DNA Diagnostics Market Overview
  • 25.2. Canada DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America DNA Diagnostics Market

  • 26.1. South America DNA Diagnostics Market Overview
  • 26.2. South America DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil DNA Diagnostics Market

  • 27.1. Brazil DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East DNA Diagnostics Market

  • 28.1. Middle East DNA Diagnostics Market Overview
  • 28.2. Middle East DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa DNA Diagnostics Market

  • 29.1. Africa DNA Diagnostics Market Overview
  • 29.2. Africa DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. DNA Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. DNA Diagnostics Market Competitive Landscape
  • 30.2. DNA Diagnostics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. DNA Diagnostics Market Other Major And Innovative Companies

  • 31.1. Becton, Dickinson and Company
  • 31.2. Laboratory Corporation
  • 31.3. Quest Diagnostics Incorporated
  • 31.4. Eurofins Scientific SE
  • 31.5. Agilent Technologies
  • 31.6. Illumina Inc
  • 31.7. PerkinElmer Inc
  • 31.8. bioMerieux SA
  • 31.9. Beckman Coulter Inc
  • 31.10. Sysmex Corporation
  • 31.11. Bio-Rad Laboratories Inc
  • 31.12. QIAGEN N.V.
  • 31.13. Natera Inc
  • 31.14. Myriad Genetics Inc.
  • 31.15. BGI Genomics Co. Ltd.

32. Global DNA Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The DNA Diagnostics Market

34. Recent Developments In The DNA Diagnostics Market

35. DNA Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 DNA Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 DNA Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 DNA Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer